About erythropoetin beta
Erythropoiesis-stimulating agent
Used for
- Treats anemia due to chronic kidney disease.
- Treats anemia in some adults receiving chemotherapy.
Usual adult dose
Chronic kidney disease: commonly 20 IU/kg intravenously or under the skin three times weekly. Chemotherapy dosing varies by regimen.
Usual dose in children
Chronic kidney disease: commonly 20 IU/kg intravenously or under the skin three times weekly; specialist adjustment is needed.
Common side effects
- High blood pressure
- Headache
- Injection-site reactions
- Blood clots
Important warnings
- May increase blood pressure and risk of heart attack, stroke, or blood clots.
- Use the lowest dose needed to reduce transfusions; excessive hemoglobin rise can be harmful.
- Not for anemia needing immediate correction or as a substitute for transfusion.
- Check iron status and blood counts during treatment.
Pregnancy
Use only when clearly needed; discuss risks and benefits with a clinician.
Breastfeeding
It is not known whether epoetin beta passes into breast milk; seek clinical guidance.
Interactions
- Blood pressure medicines may need adjustment if blood pressure rises.
- No major interactions are commonly reported; provide clinicians a complete medicine list.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.